Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learning
CROSSBRAIN aims to revolutionize brain condition treatment using implantable microbots for real-time, adaptive neuromodulation and sensing in rodent models of Parkinson's Disease and Epilepsy.
Projectdetails
Introduction
A vast number of pathological brain conditions directly involve aberrant electrical activity of the brain. CROSSBRAIN centres its technological revolution on the convergence of novel nanoactuation modalities, bleeding-edge nano-electronics, and miniaturized wireless energy harvesting and communication.
Technology Overview
Combining extreme edge computing with advanced nanomaterials featuring tailored physical properties, biocompatible coatings, and material modifications to prevent glial scarring, CROSSBRAIN will enable individualized, adaptive, and highly spatiotemporally localized actuation of brain tissue.
Sensing and Modulation
It will leverage sensing electric local field potentials, multiunit neuronal activity, and cross-modal nanomaterial-based modulation (electrical, mechanical, thermal, ionic concentration, optogenetics) of neuronal excitability with on-board intelligence.
Platform Description
The CROSSBRAIN platform comprises a swarm of wireless, implantable, MRI-compatible microbots for in vivo electrophysiology and cross-modal neuromodulation at the cell- and microcircuit levels, in freely moving rodents.
Stimulation Modalities
CROSSBRAIN delivers a multiplicity of stimulation modalities, involving:
- Electro-mechano-magneto-thermo-optical principles for modulation of nerve cell excitability.
Microbot Features
The microbots will feature both sensing and actuation electrodes, engineered with nanomaterials and viral vector coatings. They will be implanted endovascularly, deliver genetic material upon command, and operate in federation under the networked control and wireless power supply by a tiny central unit, which can be worn like an Internet of Things device.
Functionality
CROSSBRAIN will deliver autonomous or manual, closed-loop sensing, prediction, and actuation through combining multiple neuromodulation mechanisms, which will act in a synergistic and dynamic manner to optimally shape stimulation according to individual neuronal firing patterns or clinicians' needs.
Case Studies
As case studies, we will explore CROSSBRAIN action in animal models of Parkinson's Disease and Epilepsy.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 4.034.074 |
Totale projectbegroting | € 4.034.152 |
Tijdlijn
Startdatum | 1-11-2022 |
Einddatum | 31-10-2026 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATApenvoerder
- SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI DI TRIESTE
- PERCUROS BV
- NAMLAB GGMBH
- FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG
- ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE
- FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY
- UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA
- UNIVERSITY OF GLASGOW
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Dynamic Spatio-Temporal Modulation of Light by Phononic ArchitecturesDynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements. | EIC Pathfinder | € 2.552.277 | 2022 | Details |
Emerging technologies for crystal-based gamma-ray light sourcesTECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology. | EIC Pathfinder | € 2.643.187 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures
Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.
Emerging technologies for crystal-based gamma-ray light sources
TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental HealthThis project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders. | ERC COG | € 1.999.875 | 2025 | Details |
Bidirectional remote deep brain control with magnetic anisotropic nanomaterialsBRAINMASTER aims to develop a scalable, wireless neuromodulation system using magnetic nanodiscs for deep brain therapy and imaging, enhancing cognitive training and treatment for neurological disorders. | ERC STG | € 1.500.000 | 2024 | Details |
Multifunctional nano-bio INterfaces wIth deep braiN reGionsMINING aims to develop multifunctional neural endoscopes that simultaneously detect and trigger electrical and chemical signals in vivo, enhancing our understanding of brain dynamics with high resolution. | ERC COG | € 2.992.875 | 2025 | Details |
Neuromorphic Flexible Electro/chemical Interface for in-Memory Bio-Sensing and Computing.Develop a miniaturized, self-contained biosensing technology using neuromorphic devices for real-time monitoring and classification of neurodegenerative biomarkers in individualized healthcare. | ERC STG | € 1.500.000 | 2025 | Details |
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health
This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.
Bidirectional remote deep brain control with magnetic anisotropic nanomaterials
BRAINMASTER aims to develop a scalable, wireless neuromodulation system using magnetic nanodiscs for deep brain therapy and imaging, enhancing cognitive training and treatment for neurological disorders.
Multifunctional nano-bio INterfaces wIth deep braiN reGions
MINING aims to develop multifunctional neural endoscopes that simultaneously detect and trigger electrical and chemical signals in vivo, enhancing our understanding of brain dynamics with high resolution.
Neuromorphic Flexible Electro/chemical Interface for in-Memory Bio-Sensing and Computing.
Develop a miniaturized, self-contained biosensing technology using neuromorphic devices for real-time monitoring and classification of neurodegenerative biomarkers in individualized healthcare.